跳至主要内容
临床试验/IRCT20230523058271N1
IRCT20230523058271N1已完成3 期

Evaluation of the efficacy of Pentoxiphyllin in hospitalized diabetic patients with covid19

Yazd University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Diagnosis of covid in the last 24 to 48 hours
  • Candidate for hospitalization (o2sat<93% or RR>24 or Pao2/Fio2<300)
  • Covid-19 patients who are candidates for hospitalization with indications for hospitalization according to the country's guidelines, who had pulmonary infiltration in CT scan
  • Outpatients with pulmonary infiltration on CT scan
  • Age 18 to 70 years

排除标准

  • Patients who were treated with Coltera (lupinavir/ritonavir).
  • Patients with shock or hemodynamic instability
  • Drug intolerance
  • Patients with a history of Crohn's or ulcerative colitis, diarrhea or chronic malabsorption
  • Neuromuscular diseases
  • GFR less than 30 ml/min
  • History of cirrhosis, hepatitis and severe liver diseases
  • Patients receiving chemotherapy for cancer
  • Pregnancy and breastfeeding

研究者

发起方
Yazd University of Medical Sciences

相似试验